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Hormesis is an adaptive stress response implicated in longevity regulation. Schroeder et al. (2013) have now
connected stress, epigenetic changes, and aging in yeast by showing that mitochondria-derived reactive
oxygen species modulate the chromatin binding capacity of the histone demethylase Rph1p at subtelo-
meres, resulting in lifespan extension.Reactive oxygen species (ROS), including
superoxide and other free radicals, by-
products of mitochondrial respiration
(mtROS), and also products of extramito-
chondrial enzymes, are central culprits in
the macromolecular damage associated
with aging in virtually every organism
studied. Hormesis, the adaptive response
to moderate levels of stress caused by
ROS, has long been implicated in the
induction of cellular protection, and
several recent reports demonstrate that
these protective effects are sufficient to
delay aging in model organisms (Pan
et al., 2011). An increase in mtROS,
produced during the early growth and
survival phases, was shown to reduce
mtROS at later stages of survival, and ex-
tends longevity (Pan et al., 2011), in
agreement with a central role for ROS in
promoting yeast aging (Fabrizio et al.,
2001). This early mtROS signal was
suggested to be one of the mechanisms
by which reduced activity of Tor, a
conserved protein that promotes aging
in many organisms, extends yeast chro-
nological lifespan (Pan et al., 2011). A
growing body of evidence also implicates
epigenetic alterations in the aging pro-
cess in both mammalian cells and model
organisms (Dang et al., 2009). The epige-
netic control of lifespan in worms was
shown to be long lasting and trans-
generational (Greer et al., 2011), and in
mammals, alteration of the DNA methyl-
ation pattern has been repeatedly associ-
ated with gene expression modification
during the aging process (Hannum et al.,
2013).812 Cell Metabolism 17, June 4, 2013 ª2013In this issue of Cell Metabolism,
Schroeder and coworkers provide clear
evidence linking hormesis to the epige-
netic regulation of aging by defining a
pathway in which ROS modulate the
activity of the Rph1 demethylase specif-
ically at subtelomeres to remodel chro-
matin and extend lifespan (Schroeder
et al., 2013). The authors first analyzed
two published microarrays reporting
gene expression changes in response to
mtROS and identified two promoter
motifs enriched in the affected genes,
implicating the usual suspects, stress
resistance transcription factors Gis1 and
Msn2/Msn4, which are known to play
central roles in the lifespan extension
mediated by both calorie restriction (CR)
and inactivation of antiaging pathways
(Fabrizio et al., 2001) (Figure 1). Two of
these pathways, Ras-cAMP-PKA, acti-
vated by glucose, and Tor-Sch9, acti-
vated by both amino acids and glucose,
promote aging by causing the inactivation
of the serine threonine kinase Rim15 and
of transcription factors Msn2/Msn4 and
Gis1, which in turn control many stress
resistance genes, including themitochon-
drial antioxidant enzyme superoxide dis-
mutase 2 (SOD2) (Figure 1). However,
Schroeder et al. found that Gis1 and
Msn2/Msn4 together accounted for only
50% of the mtROS-dependent longevity
extension. The search for other genes
responsible for the hormesis effect re-
sulted in the identification of a novel
Rph1 demethylase-dependent coregula-
tion of lifespan extension. mtROS were
linked to Rph1 and longevity extensionElsevier Inc.via the DNA damage response proteins
Rad53 and Tel1, the yeast orthologs of
mammalian ATM and Chk2. Tel1 phos-
phorylates Rad53, which in turn phos-
phorylates Rph1 to cause subtelomeric
transcriptional repression (Figure 1).
Deletion of Rad53 or Tel1 erased the
mtROS-dependent effect on lifespan in
agreement with the increased expression
of Tel1 in the major yeast long-lived
mutants lacking Tor, Sch9, or Ras2
(Madia et al., 2009). Notably, analysis of
the Tel1 phosphorylation site in Rad53
indicated that the ROS hormesis effect
did not match that caused by a DNA
damaging agent and that the transcrip-
tional effects of ROS were distinct from
those caused by DNA damage. These
findings led the authors to conclude that
the hormetic effect of ROS does not
require, nor is it initiated by, DNA damage.
One of the epigenetic mechanisms
connecting Rph1 inactivation and
longevity described by Schroeder et al.
is the recruitment of the Sir silencing com-
plex to the subtelomeric regions. In yeast,
the Sir2 NAD+-dependent histone deace-
tylase has been implicated in subtelo-
meric silencing and longevity regulation.
However, the role of Sir2 in aging is
not clear, since Sir2 deficiency shortens
replicative lifespan but extends chrono-
logical lifespan when combined with
calorie restriction or mutations in the
Tor-Sch9 pathway (Bitterman et al.,
2003; Fabrizio et al., 2005). Schroeder
et al. performed ChIP experiments
revealing that ROS treatment enhances
the association of the Sir2-binding protein
Figure 1. ROS-Dependent Activation of the Epigenetic Regulation of Aging
A model for the effects of ROS generated during the growth/early survival phases in the activation of an
epigenetic mechanism that results in longevity extension, which is in part dependent on stress resistance
transcription factors Msn2/Msn4 and Gis1 and in part on DNA damage response genes Tel1 and Rad53
and the histone demethylase Rph1. Note that Tor and Sch9 reduce respiration and ROS generation in the
early phases of survival, but are known to promote ROS generation in the later stages of survival. Thus, the
early ROS-dependent stress appears to stimulate a hormesis effect leading to epigenetic modifications
and long-term protective effects including resistance to oxidative stress.
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dependent manner and that Sir3 is neces-
sary for subtelomeric silencing.
To gain further insights into the connec-
tion between epigenetic modifications
and longevity, it will be important in future
studies to identify the mechanisms con-
necting the Rph1 demethylase and subte-
lomeric silencing to longevity extension.
One avenue of investigation would be to
determine the effect of Rph1 and epige-
netic modifications on the expression
and/or stability of nutrients signaling
proteins, for instance in the Ras-cAMP-
PKA and Tor-Sch9 pathways, which
could explain both the Gis1/Msn2/Msn4-
dependent and -independent effects of
ROS (Figure 1). Another possibility is that
the Rph1-dependent epigenetic changes
affect unknown genes and antiagingmechanisms downstream of these
nutrient signaling pathways in agree-
ment with their role in repressing Tel1
expression. Since genetic alterations
and other interventions beneficial for
longevity, such as CR, can be associated
with enhanced mitochondrial activity and
possibly increased ROS production dur-
ing growth and the initial stages of survival
(Ocampo et al., 2012), it will be interesting
to investigate whether the effect of CR on
longevity may involve epigenetic alter-
ations analogous to those described by
Schroeder and colleagues.
In conclusion, this study not only sheds
light on the role of epigenetics on lifespan
extension but provides a mechanism for a
poorly explained connection between
hormesis and longevity. It also links both
hormesis and epigenetics to the well-Cell Metabolismestablished genes known to regulate
aging. This represents the first mecha-
nism linking ROS to the epigenetic control
of chronological longevity extension in
S. cerevisiae. The identification of mecha-
nism and/or intervention, which have the
potential to switch the epigenome of ag-
ing cells to a more youthful mode, is of
great interest, since it may identify strate-
gies leading to the rejuvenation of the cell
machineries without the need for extreme
and chronic interventions such as CR.
Together with drugs such as the mTOR
inhibitor rapamycin or inhibitors of the
growth hormone-IGF-I axis, external
stimuli that mimic those caused by
mtROS have the potential to promote
long-lasting protective states that delay
aging and prevent diseases.REFERENCES
Bitterman, K.J., Medvedik, O., and Sinclair, D.A.
(2003). Microbiol. Mol. Biol. Rev. 67, 376–399.
Dang, W., Steffen, K.K., Perry, R., Dorsey, J.A.,
Johnson, F.B., Shilatifard, A., Kaeberlein, M.,
Kennedy, B.K., and Berger, S.L. (2009). Nature
459, 802–807.
Fabrizio, P., Pozza, F., Pletcher, S.D., Gendron,
C.M., and Longo, V.D. (2001). Science 292,
288–290.
Fabrizio, P., Gattazzo, C., Battistella, L., Wei, M.,
Cheng, C., McGrew, K., and Longo, V.D. (2005).
Cell 123, 655–667.
Greer, E.L., Maures, T.J., Ucar, D., Hauswirth,
A.G., Mancini, E., Lim, J.P., Benayoun, B.A., Shi,
Y., and Brunet, A. (2011). Nature 479, 365–371.
Hannum, G., Guinney, J., Zhao, L., Zhang, L.,
Hughes, G., Sadda, S., Klotzle, B., Bibikova, M.,
Fan, J.B., Gao, Y., et al. (2013). Mol. Cell 49,
359–367.
Madia, F., Wei, M., Yuan, V., Hu, J., Gattazzo, C.,
Pham, P., Goodman, M.F., and Longo, V.D.
(2009). J. Cell Biol. 186, 509–523.
Ocampo, A., Liu, J., Schroeder, E.A., Shadel,
G.S., and Barrientos, A. (2012). Cell Metab. 16,
55–67.
Pan, Y., Schroeder, E.A., Ocampo, A., Barrientos,
A., and Shadel, G.S. (2011). Cell Metab. 13,
668–678.
Schroeder, E.A., Raimundo, N., and Shadel, G.S.
(2013). Cell Metab. 17, this issue, 954–964.17, June 4, 2013 ª2013 Elsevier Inc. 813
